Vycor Medical Inc financial data

Symbol
VYCO on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
951 Broken Sound Parkway, Suite 320, Boca Raton,, FL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 15.2 % +1.2%
Quick Ratio 4.83 % -15%
Debt-to-equity -128 % +1.45%
Return On Equity 2.97 % +35%
Return On Assets -10.6 % -44.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33.4M shares +2.28%
Common Stock, Shares, Outstanding 33.4M shares +2.28%
Entity Public Float 1.1M USD -6.18%
Common Stock, Value, Issued 3.35K USD +2.26%
Weighted Average Number of Shares Outstanding, Basic 32.9M shares +0.86%
Weighted Average Number of Shares Outstanding, Diluted 32.6M shares -12.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.59M USD +8.81%
Research and Development Expense 6.43K USD -11.4%
Operating Income (Loss) -9.15K USD -123%
Nonoperating Income (Expense) -97.8K USD +5.29%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -107K USD -69.5%
Net Income (Loss) Attributable to Parent -107K USD -53.8%
Earnings Per Share, Basic -0.01 USD/shares 0%
Earnings Per Share, Diluted -0.01 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 106K USD +84.4%
Accounts Receivable, after Allowance for Credit Loss, Current 245K USD +14%
Inventory, Net 222K USD -5.11%
Assets, Current 696K USD +19.1%
Property, Plant and Equipment, Net 193K USD -23.7%
Operating Lease, Right-of-Use Asset 104K USD -30.8%
Assets 998K USD +0.59%
Accounts Payable, Current 148K USD +25.3%
Liabilities, Current 4.5M USD +10.4%
Operating Lease, Liability, Noncurrent 52.2K USD -48%
Liabilities 4.69M USD +8.58%
Accumulated Other Comprehensive Income (Loss), Net of Tax 128K USD 0%
Retained Earnings (Accumulated Deficit) -33.3M USD -1.32%
Stockholders' Equity Attributable to Parent -3.69M USD -11%
Liabilities and Equity 998K USD +0.59%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.89K USD -92.3%
Net Cash Provided by (Used in) Financing Activities -16K USD -13%
Net Cash Provided by (Used in) Investing Activities 662 USD +130%
Common Stock, Shares Authorized 55M shares 0%
Common Stock, Shares, Issued 33.5M shares +2.27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13.4K USD -225%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.37K USD -2.14%
Deferred Tax Assets, Valuation Allowance 4.64M USD -0.41%
Operating Lease, Liability 100K USD -31.1%
Depreciation 15.6K USD +1.73%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -107K USD -53.8%
Property, Plant and Equipment, Gross 1.4M USD +0.3%
Operating Lease, Liability, Current 48.2K USD +6.26%
Lessee, Operating Lease, Liability, to be Paid, Year Two 53.7K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 52.1K USD +1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 53.7K USD
Preferred Stock, Shares Issued 270K shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 29.4M USD +0.23%
Preferred Stock, Shares Outstanding 270K shares 0%
Share-based Payment Arrangement, Expense 2.36K USD -76.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%